Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03167255 · ClinicalTrials.gov registry record · Phase 2

Extension Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)

A Phase 2 study of Duchenne Muscular Dystrophy, sponsored by NS Pharma.

Completed
Registry status
Phase 2
Development phase
16
Enrollment target
6
Study locations

NCT03167255 is a Phase 2 study of Duchenne Muscular Dystrophy that has completed, run by NS Pharma. The registered enrollment target is 16 participants, below the 412-participant average among 48 other Duchenne Muscular Dystrophy trials with a reported enrollment target (96% lower). The trial reports 6 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03167255, a Phase 2 study of Duchenne Muscular Dystrophy, has completed, sponsored by NS Pharma.

COMPLETED
Registry status
Phase 2
Development phase
16 participants
Enrollment target
6
Study locations

Study Summary

This is an open-label, extension study of NS-065/NCNP-01 administered intravenously once weekly for an additional 192 weeks to boys with DMD who complete Study NS-065/NCNP-01-201.

Conditions Studied

Duchenne Muscular Dystrophy

Interventions

  • DRUG NS-065/NCNP-01

Study Locations (6)

California

  • UC Davis - Sacramento

Illinois

  • Lurie Children's Hospital - Chicago

Missouri

  • Washington University - St Louis

North Carolina

  • Duke University Medical Center - Durham

Virginia

  • Children's Hospital of Richmond at VCU - Richmond

Alberta

  • Alberta Children's Hospital - Calgary

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2017-07-06
Est. Completion 2021-11-15
Phase Phase 2

Sponsor

NS Pharma

11 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03167255

The ClinicalTrials.gov registry entry for NCT03167255 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 412-participant average among 48 other Duchenne Muscular Dystrophy trials with a reported enrollment target (96% lower). The listed sponsor is NS Pharma, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Duchenne Muscular Dystrophy appearing as the primary indexed condition, and to 1 intervention - of which NS-065/NCNP-01 is the first listed.

NCT03167255 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Illinois, Missouri.

Frequently Asked Questions

What is clinical trial NCT03167255 about?

NCT03167255 is a clinical study titled "Extension Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)". This is an open-label, extension study of NS-065/NCNP-01 administered intravenously once weekly for an additional 192 weeks to boys with DMD who complete Study NS-065/NCNP-01-201.

What is the current status of trial NCT03167255?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2017-07-06. Estimated completion is 2021-11-15.

What conditions does trial NCT03167255 study?

This clinical trial studies the following conditions: Duchenne Muscular Dystrophy.

What interventions are being tested in trial NCT03167255?

The interventions under investigation include: NS-065/NCNP-01 (DRUG).

Who is sponsoring clinical trial NCT03167255?

This trial is sponsored by NS Pharma, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03167255 being conducted?

This trial has 6 study locations across California, Illinois, Missouri, North Carolina, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Duchenne Muscular Dystrophy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Duchenne Muscular Dystrophy

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.